September 18, 2012
Article
Clinical Articles
As basic research on new targets for rheumatoid arthritis (RA) treatment continues, novel therapies move through phase II trials.
September 18, 2012
Article
Clinical Articles
The Janus kinase ( JAK) molecule is an immunomodulating signal transduction agent, which has emerged as a new target for rheumatoid arthritis (RA) research.
September 18, 2012
Article
Clinical Articles
During the past decade, changes in the treatment of rheumatoid arthritis (RA) have been accumulating faster than treatment experience can be evaluated.
September 18, 2012
Article
Clinical Articles
Despite decades of investigation, the causes of rheumatoid arthritis (RA) have remained elusive.